Edition:
United States

Sartorius Stedim Biotech SA (STDM.PA)

STDM.PA on Paris Stock Exchange

106.70EUR
21 Aug 2018
Change (% chg)

-- (--)
Prev Close
€106.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,104
52-wk High
€107.30
52-wk Low
€50.13

Chart for

About

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and... (more)

Overall

Beta: 0.47
Market Cap(Mil.): €9,614.39
Shares Outstanding(Mil.): 92.18
Dividend: 0.46
Yield (%): 0.44

Financials

  STDM.PA Industry Sector
P/E (TTM): 56.17 37.42 30.39
EPS (TTM): 1.87 -- --
ROI: 17.15 14.28 12.61
ROE: 20.16 17.48 14.80

BRIEF-Sartorius Stedim Biotech Net Profit Up at 47.1 Million Euros

* IN Q1 INCREASED ITS SALES REVENUE IN CONSTANT CURRENCIES BY 9.8% (REPORTED 4.6%) TO 281.1 MILLION EUROS.

Apr 24 2018

BRIEF-Sartorius Stedim Biotech And Penn State University Entered Into Collaborative Partnership

* SARTORIUS STEDIM BIOTECH AND PENN STATE UNIVERSITY ENTERED INTO COLLABORATIVE PARTNERSHIP TO ADVANCE MULTIDISCIPLINARY TEACHING AND RESEARCH IN BIOTECHNOLOGY Source text : https://bit.ly/2qygOm0 Further company coverage: (Gdynia Newsroom)

Apr 16 2018

BRIEF-Sartorius Stedim Biotech Launches New Ambr 250 High Throughput Bioreactor System

* LAUNCHES NEW AMBR 250 HIGH THROUGHPUT BIOREACTOR SYSTEM FOR PERFUSION CULTURE Source text: http://bit.ly/2FKA8C8 Further company coverage: (Gdynia Newsroom:)

Mar 14 2018

Earnings vs. Estimates